Patents by Inventor Paul Bernasconi

Paul Bernasconi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20150196031
    Abstract: The present invention relates to polypeptides, preferably from Drosophila melanogaster (DmShal) as target for insecticides.
    Type: Application
    Filed: January 28, 2015
    Publication date: July 16, 2015
    Applicant: BASF SE
    Inventors: Paul Bernasconi, John Dorsch, Lynn Stam, Scott Zitko, Nancy B. Ranki, Mike Griswold, Franz-Josef Braun, Gang Lu, Robert D. Kirkton, Barbara Wedel, Joachim Dickhaut
  • Patent number: 9029080
    Abstract: The present invention relates to polypeptides, preferably from Drosophila melanogaster (DmShaI) as target for insecticides.
    Type: Grant
    Filed: November 5, 2009
    Date of Patent: May 12, 2015
    Assignee: BASF SE
    Inventors: Paul Bernasconi, John Dorsch, Lynn Stam, Scott Zitko, Nancy B. Rankl, Mike Griswold, Franz-Josef Braun, Gang Lu, Robert D. Kirkton, Barbara Wedel, Joachim Dickhaut, Angela Hofhine, Jennifer Zink, Fae Malone, Daniel Houtz, Steffen Gro╬▓, Ramani Kandasamy, Damian O' Brecht London, Thomas M. Gurganus
  • Publication number: 20110263585
    Abstract: The present invention relates to polypeptides, preferably from Drosophila melanogaster (DmShaI) as target for insecticides.
    Type: Application
    Filed: November 5, 2009
    Publication date: October 27, 2011
    Applicant: BASF SE
    Inventors: Paul Bernasconi, John Dorsch, Lynn Stam, Scott Zitko, Nancy B. Rankl, Mike Griswold, Franz-Josef Braun, Gang Lu, Robert D. Kirkton, Barbara Wedel, Joachim Dickhaut, Angela Hofhine, Jennifer Zink, Fae Malone, Daniel Houtz, Steffen Gross, Ramani Kandasamy, Damian London, Thomas M. Gurganus
  • Patent number: 7799328
    Abstract: The present invention relates to a method of treating or preventing weight loss of patients with inflammatory bowel diseases comprising administering to said patients an effective amount of Saccharomyces boulardii.
    Type: Grant
    Filed: December 23, 2004
    Date of Patent: September 21, 2010
    Assignee: Biocodex
    Inventors: Bernard Hublot, Herve Groux, Rene Levy, Marie-Emmanuelle Le Guern, Paul Bernasconi
  • Publication number: 20060247315
    Abstract: The present invention relates to the use of L-citrulline (I) for the preparation of a medicament intended for the treatment of pathologies linked to an intestinal insufficiency.
    Type: Application
    Filed: June 30, 2006
    Publication date: November 2, 2006
    Applicants: BIOCODEX, UNIVERSITE RENE DESCARTES PARIS 5
    Inventors: Sylwia Osowska-Vincent, Christophe Moinard, Luc Cynober, Marie-Emmanuelle Le Guern, Bernard Hublot, Paul Bernasconi
  • Publication number: 20060165657
    Abstract: The present invention relates to compositions comprising a baculovirus vector and a pharmaceutically acceptable carrier to deliver the baculovirus vector onto or into the skin of a mammal to achieve a cosmetic effect. The present invention also provides methods of producing various cosmetic effects by administering the compositions of this invention onto or into the skin of a mammal.
    Type: Application
    Filed: February 4, 2004
    Publication date: July 27, 2006
    Inventors: Paul Bernasconi, William Janzen, Jennings Worley
  • Publication number: 20060140973
    Abstract: The present invention relates to a method of treating or preventing weight loss of patients with inflammatory bowel diseases comprising administering to said patients an effective amount of Saccharomyces boulardii.
    Type: Application
    Filed: December 23, 2004
    Publication date: June 29, 2006
    Inventors: Bernard Hublot, Herve Groux, Rene Levy, Marie-Emmanuelle Le Guern, Paul Bernasconi
  • Publication number: 20050239891
    Abstract: The present invention relates to the use of L-citrulline (I) for the preparation of a medicament intended for the treatment of pathologies linked to an intestinal insufficiency.
    Type: Application
    Filed: July 8, 2004
    Publication date: October 27, 2005
    Inventors: Sylwia Osowska-Vincent, Christophe Moinard, Luc Cynober, Marie-Emmanuelle Le Guern, Bernard Hublot, Paul Bernasconi
  • Patent number: 6589744
    Abstract: A method and kit for detecting nucleic acid modification enzyme activity by monitoring the change in fluorescence polarization upon the change in mass of a fluorescently labeled oligo. A nucleic acid substrate comprises a template having a nucleic acid sequence annealed to a labeled oligo, wherein there is a nick or break located between the adjacent ends of the template and the labeled oligo. A nucleic acid modification enzyme is added to the substrate to form a reaction mixture. A stop reagent may or may not be used to further process the reaction mixture. A test compound is added to the reaction mixture, preferably prior to addition of the nucleic acid modification enzyme, whereby the resulting fluorescence polarization signal is compared to a standard signal to determine if the test compound inhibits nucleic acid modification enzyme activity.
    Type: Grant
    Filed: November 26, 2001
    Date of Patent: July 8, 2003
    Assignee: Syngenta Participations AG
    Inventors: Robert Calvin Dutcher, Michael William Bauer, Paul Bernasconi
  • Patent number: 6586190
    Abstract: A parallel high throughput method and kit for the discovery of small molecule interactors of target proteins, in particular, target proteins expressed from entire genomes or subsets thereof. The target module is prepared by binding selectively a target protein, modified to allow its detection, to a surrogate ligand that is linked to an individually detectable bead. Sets of target modules are mixed together in each chamber of a multi-chamber container. A test compound or collection of test compounds is added to each chamber, and the interaction of a compound with each target module is observed. A compound that is specific for a particular target protein will displace that protein from its target module. The identity of the target module so disrupted is determined by identifying the particular bead to which the displaced target protein was attached.
    Type: Grant
    Filed: July 30, 2001
    Date of Patent: July 1, 2003
    Assignee: Syngenta Participations AG
    Inventors: Paul Bernasconi, Ray Donald Carpenter, Gary Keith Powell, Robert Michael Petrovich, Kimberly Ann White, Jennifer Audrey Hunt
  • Publication number: 20030099953
    Abstract: A method and kit for detecting nucleic acid modification enzyme activity by monitoring the change in fluorescence polarization upon the change in mass of a fluorescently labeled oligo. A nucleic acid substrate comprises a template having a nucleic acid sequence annealed to a labeled oligo, wherein there is a nick or break located between the adjacent ends of the template and the labeled oligo. A nucleic acid modification enzyme is added to the substrate to form a reaction mixture. A stop reagent may or may not be used to further process the reaction mixture. A test compound is added to the reaction mixture, preferably prior to addition of the nucleic acid modification enzyme, whereby the resulting fluorescence polarization signal is compared to a standard signal to determine if the test compound inhibits nucleic acid modification enzyme activity.
    Type: Application
    Filed: November 26, 2001
    Publication date: May 29, 2003
    Inventors: Robert Calvin Dutcher, Michael William Bauer, Paul Bernasconi
  • Publication number: 20020137888
    Abstract: A parallel high throughput method and kit for the discovery of small molecule interactors of target proteins, in particular, target proteins expressed from entire genomes or subsets thereof. The target module is prepared by binding selectively a target protein, modified to allow its detection, to a surrogate ligand that is linked to an individually detectable bead. Sets of target modules are mixed together in each chamber of a multi-chamber container. A test compound or collection of test compounds is added to each chamber, and the interaction of a compound with each target module is observed. A compound that is specific for a particular target protein will displace that protein from its target module. The identity of the target module so disrupted is determined by identifying the particular bead to which the displaced target protein was attached.
    Type: Application
    Filed: July 30, 2001
    Publication date: September 26, 2002
    Inventors: Paul Bernasconi, Ray D. Carpenter, Gary K. Powell, Robert M. Petrovich, Kimberly A. White, Jennifer A. Hunt
  • Patent number: 6307037
    Abstract: The invention relates to genes isolated from Ashbya gossypii that code for proteins essential for normal fungal growth and development. The invention also includes the methods of using these proteins to discover new fungicides, based on the essentiality of the gene for normal growth and development. The invention can also be used in a screening assay to identify inhibitors that are potential fungicides.
    Type: Grant
    Filed: July 21, 2000
    Date of Patent: October 23, 2001
    Assignee: Syngenta Participations AG
    Inventors: Thomas Deane Gaffney, Albert Flavier, Michelle M. Cloyd Kirksey, Peter Phillippsen, Frederick Dietrich, Jurgen Wendland, Paul Bernasconi, Kimberly White, Witold Filipowicz
  • Patent number: 5633437
    Abstract: The present invention provides a novel gene and enzyme isolated from cocklebur (Xanthium sp.) which confers resistance to several structurally unrelated classes of herbicides in plants, plant tissues and seeds. In particular, the class of herbicides consists of herbicides wherein acetolactate synthase (ALS) is the site of action and includes sulfonylureas, imidazolinones, triazolopyrimidines, pyrimidyloxybenzoates and phthalides.
    Type: Grant
    Filed: October 11, 1994
    Date of Patent: May 27, 1997
    Assignee: Sandoz Ltd.
    Inventors: Paul Bernasconi, Alison R. Woodworth